SCHEMBL18955307

SCHEMBL18955307

CCOC(=O)CCN1C(=O)C(=O)c2cc(S(=O)(=O)O)ccc21.[NaH]

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ CASP3 P42574 9/20 0.47
▸ CASP7 P55210 9/20 0.47
▸ MAPT P10636 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CASP1 P29466 2/20 0.43
▸ CASP6 P55212 1/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ RCE1 Q9Y256 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18955348 0.93 ALDH1A1 (0.53) ALDH1A1CASP3CASP7MAPTHTT
SCHEMBL18955305 0.88 ALDH1A1 (0.55) ALDH1A1CASP3CASP7MAPTHTT
SCHEMBL18955049 0.88 CA1 (0.56) ALDH1A1CA12CA1CA2CA9
SCHEMBL18955210 0.88 ALDH1A1 (0.71) ALDH1A1CASP3CASP7MAPTHTT
SCHEMBL18954856 0.83 CASP3 (0.57) CASP3CASP7CASP6CA12CA1
SCHEMBL18955128 0.82 ALDH1A1 (0.58) ALDH1A1CASP3MAPTHTTHSD17B10
SCHEMBL18955190 0.82 CA1 (0.54) ALDH1A1CASP3CASP7CA12CA1
SCHEMBL18955347 0.82 ALDH1A1 (0.53) ALDH1A1CASP3CASP7MAPTHTT
SCHEMBL18954765 0.80 ALDH1A1 (0.56) ALDH1A1MAPTHTTHSD17B10MEN1
SCHEMBL18974747 0.79 CES1 (0.59) ALDH1A1MAPTHTTHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback